Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasculitis

J G Smith1

  • 1University of South Alabama, Mobile, USA.

The Journal of Dermatology
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

This study reviews vasculitis classifications, etiologies, and diagnostic markers like antineutrophil cytoplasmic antibodies (ANCA). It highlights treatments for cutaneous and systemic vasculitis, including colchicine, dapsone, prednisone, and co-trimoxazole for Wegener's granulomatosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for B(s)(0) → μ+ μ- and B(0) → μ+ μ- decays in pp collisions at sqrt[s] = 7 TeV.

Physical review letters·2011
Same author

Search for new physics with a monojet and missing transverse energy in pp collisions at √s = 7 TeV.

Physical review letters·2011
Same author

Search for hadronic decays of a light Higgs boson in the radiative decay Υ→γA0.

Physical review letters·2011
Same author

Measurement of the inclusive jet cross section in pp collisions at √s = 7 TeV.

Physical review letters·2011
Same author

Search for three-jet resonances in pp collisions at square root(s)=7  TeV.

Physical review letters·2011
Same author

Measurement of the t-channel single top quark production cross section in pp collisions at √s=7  TeV.

Physical review letters·2011
Same journal

Real-World Effectiveness of Tildrakizumab in Japanese Patients With Psoriasis: Analyses Stratified by Prior Systemic Therapy, Maintenance of Early Responses, and Achievement of Delayed Responses.

The Journal of dermatology·2026
Same journal

Clinical Characteristics and Treatment Patterns of Hyperhidrosis in Northern Hokkaido: A Single-Center Retrospective Descriptive Study.

The Journal of dermatology·2026
Same journal

Sparing of the Nipple-Areolar Complex and Periareolar Skin as a Diagnostic Clue for Radiation-Induced Morphea of the Breast.

The Journal of dermatology·2026
Same journal

Bullous Pemphigoid With Blister Sparing in Areas of Neurologic Impairment Caused by Syringomyelia.

The Journal of dermatology·2026
Same journal

Demodex Infestation in Patients With Atopic Dermatitis Treated With Dupilumab: A Case-Control Study.

The Journal of dermatology·2026
Same journal

A Serum N-Glycan Ratio Associated With Disease Severity and Treatment Response in Psoriasis.

The Journal of dermatology·2026
See all related articles

Area of Science:

  • Immunology
  • Pathology
  • Dermatology

Background:

  • Vasculitis encompasses diverse disorders characterized by blood vessel inflammation and necrosis.
  • Existing classifications by Fauci, Gibson & Ryan, and Jennette et al. categorize vasculitis based on clinical presentation, histology, and etiology.
  • Etiologies are multifactorial, including infections, autoimmune diseases, malignancy, and drug reactions.

Purpose of the Study:

  • To provide a comprehensive overview of vasculitis, including its classifications, causes, diagnostic approaches, and therapeutic strategies.
  • To discuss the role of antineutrophil cytoplasmic antibodies (ANCA) in diagnosing and managing specific vasculitic syndromes.
  • To highlight current and emerging treatments for both cutaneous and systemic vasculitis.

Main Methods:

Related Experiment Videos

  • Review of existing literature on vasculitis classifications and diagnostic markers.
  • Discussion of immunological assays for detecting antineutrophil cytoplasmic antibodies (ANCA), such as indirect immunofluorescence and ELISA.
  • Analysis of therapeutic interventions for various forms of vasculitis, including pharmacological agents and their combinations.

Main Results:

  • Multiple classification systems exist for vasculitis, with varying criteria.
  • Antineutrophil cytoplasmic antibodies (ANCA), specifically cANCA (proteinase 3) and pANCA (myeloperoxidase and others), are crucial diagnostic and prognostic markers.
  • Effective treatments for cutaneous vasculitis include colchicine, dapsone, and prednisone, while systemic vasculitis management is more complex, with co-trimoxazole showing promise for Wegener's granulomatosis.

Conclusions:

  • Vasculitis is a complex group of diseases with diverse etiologies and presentations.
  • Accurate classification and diagnosis, aided by ANCA testing, are essential for effective management.
  • Treatment strategies vary significantly based on the type and severity of vasculitis, with ongoing research into novel therapeutic agents and combinations.